Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Frank KJ"'
Publikováno v:
International Journal of Nanomedicine, Vol 2012, Iss default, Pp 5757-5768 (2012)
Kerstin J Frank,1,3 Ulrich Westedt,2 Karin M Rosenblatt,2 Peter Hölig,2 Jörg Rosenberg,2 Markus Mägerlein,2 Gert Fricker,3 Martin Brandl11Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark; 2Abbott GmbH
Externí odkaz:
https://doaj.org/article/a7cfd98168804b1ead9702d796ccc8f1
Autor:
Frank KJ; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Mulero-Sánchez A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Berninger A; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Ruiz-Cañas L; Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas 'Alberto Sols' (IIBM), CSIC-UAM, 28029 Madrid, Spain; Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Bosma A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Görgülü K; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Wu N; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Diakopoulos KN; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Kaya-Aksoy E; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Ruess DA; Department of General and Visceral Surgery, Center of Surgery, Medical Center-University of Freiburg, 79106 Freiburg, Germany., Kabacaoğlu D; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Schmidt F; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Kohlmann L; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., van Tellingen O; Division of Pharmacology, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Thijssen B; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., van de Ven M; Mouse Clinic for Cancer and Aging Research, Preclinical Intervention Unit, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Proost N; Mouse Clinic for Cancer and Aging Research, Preclinical Intervention Unit, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands., Kossatz S; Department of Nuclear Medicine at Klinikum Rechts der Isar and Central Institute for Translational Cancer Research (TranslaTUM), Technische Universität München, 81675 Munich, Germany; Department of Chemistry, Technische Universität München, 85748 Munich, Germany., Weber WA; Department of Nuclear Medicine at Klinikum Rechts der Isar and Central Institute for Translational Cancer Research (TranslaTUM), Technische Universität München, 81675 Munich, Germany., Sainz B Jr; Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas 'Alberto Sols' (IIBM), CSIC-UAM, 28029 Madrid, Spain; Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Algül H; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Lesina M; Comprehensive Cancer Center Munich at Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany., Mainardi S; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands. Electronic address: s.mainardi@nki.nl.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Nov 15; Vol. 3 (11), pp. 100815.
Autor:
Leusink, Frank KJ, van Es, Robert JJ, de Bree, Remco, de Jong, Robert J Baatenburg, van Hooff, Sander R, Holstege, Frank CP, Slootweg, Piet J, Brakenhoff, Ruud H, Takes, Robert P
Publikováno v:
In Lancet Oncology December 2012 13(12):e554-e561
Autor:
Mejia, Daniel1 (AUTHOR), Burnett, Lydia2 (AUTHOR), Hebdon, Nicholas1 (AUTHOR), Stevens, Peter3 (AUTHOR), Shiber, Alexis1 (AUTHOR), Cranston, Clay1 (AUTHOR), DeGreeff, Lauryn2 (AUTHOR), Waldrop, Lindsay D.1 (AUTHOR) waldrop@chapman.edu
Publikováno v:
Scientific Reports. 2/28/2024, Vol. 14 Issue 1, p1-11. 11p.
Autor:
Margolskee A; University of Manchester, United Kingdom. Electronic address: alison.margolskee@manchester.ac.uk., Darwich AS; University of Manchester, United Kingdom., Pepin X; AstraZeneca, United Kingdom; Sanofi, France., Pathak SM; Simcyp Ltd., United Kingdom., Bolger MB; Simulations Plus, Inc., United States., Aarons L; University of Manchester, United Kingdom., Rostami-Hodjegan A; University of Manchester, United Kingdom; Simcyp Ltd., United Kingdom., Angstenberger J; AbbVie, Germany., Graf F; AbbVie, Germany., Laplanche L; AbbVie, Germany., Müller T; AbbVie, Germany., Carlert S; AstraZeneca, Sweden., Daga P; AstraZeneca, United States., Murphy D; AstraZeneca, United Kingdom., Tannergren C; AstraZeneca, Sweden., Yasin M; AstraZeneca, United Kingdom., Greschat-Schade S; Bayer Pharma AG, Germany., Mück W; Bayer Pharma AG, Germany., Muenster U; Bayer Pharma AG, Germany., van der Mey D; Bayer Pharma AG, Germany., Frank KJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Germany., Lloyd R; GlaxoSmithKline, United Kingdom., Adriaenssen L; Janssen, Belgium., Bevernage J; Janssen, Belgium., De Zwart L; Janssen, Belgium., Swerts D; Janssen, Belgium., Tistaert C; Janssen, Belgium., Van Den Bergh A; Janssen, Belgium., Van Peer A; Janssen, Belgium., Beato S; Novartis, Switzerland., Nguyen-Trung AT; Novartis, Switzerland., Bennett J; Pfizer, United Kingdom., McAllister M; Pfizer, United Kingdom., Wong M; Pfizer, United Kingdom., Zane P; Sanofi, United States., Ollier C; Sanofi, France., Vicat P; Sanofi, France., Kolhmann M; Sanofi, Germany., Marker A; Sanofi, Germany., Brun P; Sanofi, France., Mazuir F; Sanofi, France., Beilles S; Sanofi, France., Venczel M; Sanofi, Germany., Boulenc X; Sanofi, France., Loos P; Sanofi, Germany., Lennernäs H; Uppsala University, Sweden., Abrahamsson B; AstraZeneca, Sweden.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2017 Jan 01; Vol. 96, pp. 598-609. Date of Electronic Publication: 2016 Sep 23.
Publikováno v:
Experimental Hematology & Oncology. 11/4/2023, Vol. 12 Issue 1, p1-19. 19p.
Autor:
Locher K; Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany; Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany., Borghardt JM; Department of Clinical Pharmacy & Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Kelchstraße 31, 12169 Berlin, Germany., Frank KJ; Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany., Kloft C; Department of Clinical Pharmacy & Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Kelchstraße 31, 12169 Berlin, Germany., Wagner KG; Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany. Electronic address: kgwagner@uni-bonn.de.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2016 Aug; Vol. 105, pp. 166-75. Date of Electronic Publication: 2016 Jun 11.
Autor:
Frank KJ; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany. Electronic address: Kerstin_Julia.Frank@Boehringer-Ingelheim.com., Boeck G; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2016 May 25; Vol. 87, pp. 112-7. Date of Electronic Publication: 2016 Mar 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Frank KJ; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany., Locher K; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany., Zecevic DE; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany., Fleth J; Drug Metabolism and Pharmacokinetics, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany., Wagner KG; Pharmaceutical Development, Boehringer-Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany. Electronic address: KGWagner@uni-bonn.de.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2014 Sep 30; Vol. 61, pp. 32-9. Date of Electronic Publication: 2014 Jan 08.